UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INVX
1826
Innovex International
INVX
$2.04B
| $1.66M | ﹤0.01% |
89,304
-46,282
| -34% | -$770K |
|
1827
Southside Bancshares
SBSI
$953M
| $1.65M | ﹤0.01% |
58,491
-35,422
| -38% | -$1.07M |
|
1828
SI-BONE Inc
SIBN
$844M
| $1.65M | ﹤0.01% |
112,202
-28,220
| -20% | -$461K |
|
1829
KB Financial Group
KB
$42.4B
| $1.65M | ﹤0.01% |
19,905
+3,925
| +25% | +$322K |
|
1830
Summit Therapeutics
SMMT
$11.9B
| $1.64M | ﹤0.01% |
79,589
-7,300
| -8% | -$177K |
|
|
FBRT
1831
Franklin BSP Realty Trust
FBRT
$649M
| $1.64M | ﹤0.01% |
151,304
+76,274
| +102% | +$840K |
|
1832
Limbach Holdings
LMB
$552M
| $1.62M | ﹤0.01% |
16,704
-13,119
| -44% | -$1.58M |
|
1833
Janux Therapeutics
JANX
$1B
| $1.62M | ﹤0.01% |
66,325
-45,037
| -40% | -$1.1M |
|
1834
Hamilton Insurance Group
HG
$3.44B
| $1.61M | ﹤0.01% |
65,069
-55,654
| -46% | -$1.27M |
|
1835
Herbalife
HLF
$1.21B
| $1.61M | ﹤0.01% |
190,644
-102,316
| -35% | -$965K |
|
1836
Lennar Class B
LEN.B
$20.2B
| $1.61M | ﹤0.01% |
13,403
-618
| -4% | -$73.3K |
|
|
GPGI
1837
GPGI Inc
GPGI
$4.16B
| $1.61M | ﹤0.01% |
77,125
-40,176
| -34% | -$695K |
|
1838
Community Trust Bancorp
CTBI
$1.41B
| $1.61M | ﹤0.01% |
28,691
-19,326
| -40% | -$1.08M |
|
1839
Hertz
HTZ
$756M
| $1.6M | ﹤0.01% |
235,163
-209,207
| -47% | -$1.34M |
|
1840
Hanmi Financial
HAFC
$939M
| $1.58M | ﹤0.01% |
63,919
-64,272
| -50% | -$1.58M |
|
1841
Liquidity Services
LQDT
$1.28B
| $1.57M | ﹤0.01% |
57,272
-47,480
| -45% | -$1.22M |
|
1842
Tidewater
TDW
$4.46B
| $1.57M | ﹤0.01% |
29,456
-16,674
| -36% | -$914K |
|
1843
Amalgamated Financial
AMAL
$1.48B
| $1.57M | ﹤0.01% |
57,723
-30,487
| -35% | -$906K |
|
1844
Helen of Troy
HELE
$680M
| $1.56M | ﹤0.01% |
62,099
-35,073
| -36% | -$849K |
|
1845
Vicor
VICR
$9.63B
| $1.55M | ﹤0.01% |
31,219
-32,841
| -51% | -$1.6M |
|
1846
Navitas Semiconductor
NVTS
$3.44B
| $1.55M | ﹤0.01% |
+214,378
| New | +$1.43M |
|
1847
Enact Holdings
ACT
$6.67B
| $1.55M | ﹤0.01% |
40,323
+14,051
| +53% | +$521K |
|
1848
Applied Optoelectronics
AAOI
$11.2B
| $1.54M | ﹤0.01% |
59,561
-47,907
| -45% | -$1.22M |
|
1849
Tootsie Roll Industries
TR
$2.97B
| $1.54M | ﹤0.01% |
37,864
-19,021
| -33% | -$720K |
|
|
DHC
1850
Diversified Healthcare Trust
DHC
$2.04B
| $1.54M | ﹤0.01% |
349,339
-163,943
| -32% | -$625K |
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.